✦ LIBER ✦

Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2

✍ Scribed by Karim Alavi; Marshall Z Schwartz; Juan P Palazzo; Rajeev Prasad

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth factor based therapies and intest

✍ Roger Yazbeck; Gordon S. Howarth; Catherine A. Abbott 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Glucagon like peptide-2 (GLP-2) differen

✍ P. Jiang; A. Vegge; J.M. Wan; T. Thymann; P.T. Sangild 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Pathologic Effects of Hepatocyte Growth

✍ Zwintscher, N.P.; Salgar, S.K.; Newton, C.R.; Steele, S.R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Hepatocyte growth factor treatment ameli

✍ L.Grier Arthur; Marshall Z Schwartz; Keith A Kuenzler; Ruth Birbe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

576 Exogenous Glucagon-Like Peptide 2 Th

✍ Lim, David W.; Wales, Paul W.; Vine, Donna F.; Borthwick, Faye; Nation, Patrick 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

697 Role of the Intestinal Epithelial-In

✍ Dong, Charlotte X.; Solomon, Chloe J.; Zhao, Wen; Gonska, Tanja; Brubaker, Patri 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB